title: Differential cytokine gene expression according to outcome in a hamster model of leptospirosis.
abstract: BACKGROUND
  Parameters predicting the evolution of leptospirosis would be useful for clinicians, as well as to better understand severe leptospirosis, but are scarce and rarely validated. Because severe leptospirosis includes septic shock, similarities with predictors evidenced for sepsis and septic shock were studied in a hamster model.
  
  
  RESULTS
  Using an LD50 model of leptospirosis in hamsters, we first determined that 3 days post-infection was a time-point that allowed studying the regulation of immune gene expression and represented the onset of the clinical signs of the disease. In the absence of tools to assess serum concentrations of immune effectors in hamsters, we determined mRNA levels of various immune genes, especially cytokines, together with leptospiraemia at this particular time-point. We found differential expression of both pro- and anti-inflammatory mediators, with significantly higher expression levels of tumor necrosis factor alpha, interleukin 1alpha, cyclo-oxygenase 2 and interleukin 10 genes in nonsurvivors compared to survivors. Higher leptospiraemia was also observed in nonsurvivors. Lastly, we demonstrated the relevance of these results by comparing their respective expression levels using a LD100 model or an isogenic high-passage nonvirulent variant.
  
  
  CONCLUSIONS
  Up-regulated gene expression of both pro- and anti-inflammatory immune effectors in hamsters with fatal outcome in an LD50 model of leptospirosis, together with a higher Leptospira burden, suggest that these gene expression levels could be predictors of adverse outcome in leptospirosis.
authors.affiliation: Institut Pasteur de Nouvelle-Calédonie, Nouméa, New Caledonia.
authors.forename: Frédérique
authors.initials: F
authors.lastname: Vernel-Pauillac
authors.forename: Cyrille
authors.initials: C
authors.lastname: Goarant
mesh_terms: D000818:Animals; D006224:Cricetinae; D051546:Cyclooxygenase 2 / Q000235:genetics; D016207:Cytokines / Q000235:genetics*; D004195:Disease Models, Animal; D005786:Gene Expression Regulation / Q000235:genetics / Q000276:immunology; D016753:Interleukin-10 / Q000235:genetics; D053582:Interleukin-1alpha / Q000235:genetics; D007922:Leptospirosis / Q000235:genetics* / Q000276:immunology*; D008647:Mesocricetus / Q000235:genetics / Q000276:immunology* / Q000382:microbiology*; D016133:Polymerase Chain Reaction; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics
chemical_list: D016207:Cytokines; D053582:Interleukin-1alpha; D014409:Tumor Necrosis Factor-alpha; D016753:Interleukin-10; D051546:Cyclooxygenase 2